Btai analyst ratings

Author: ezar

August undefined, 2024

Web6 rows · BioXcel Therapeutics Inc. analyst ratings, historical stock prices, earnings … WebApr 10, 2024 · Shares of BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Rating) have received an average rating of “Moderate Buy” from the eight analysts that are presently covering the company, Marketbeat ...

Goldman Sachs Reaffirms Their Hold Rating on Bioxcel …

WebBTAI will report Q1 earnings on 05/08/2024 Actual Analyst Range Consensus 1.00 0.00 -1.00 -2.00 More Overview Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only;... WebBioXcel Therapeutics Stock (NASDAQ:BTAI), Analyst Ratings, Price Targets, … brannings s plainfield-xd

BTAI BioXcel Therapeutics Inc. Stock Price & News - WSJ

WebBioxcel Therapeutics Inc (BTAI) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... Canaccord lowered the firm’s price target on BioXcel Therapeutics to $75 from $76 and keeps a Buy rating... 24d ago. BTAI. WebAnalysts Offer Insights on Healthcare Companies: Bioxcel Therapeutics (BTAI), Avidity Biosciences (RNA) and Sensei Biotherapeutics (SNSE) Aug. 10, 2024 at 6:10 a.m. ET on TipRanks.com Recap:... WebApr 10, 2024 · BioXcel Therapeutics, Inc. ( NASDAQ:BTAI – Get Rating) has been assigned an average recommendation of “Moderate Buy” from the eight brokerages that are covering the stock, MarketBeat.com... brannings garage in cottondale fl

BioXcel Therapeutics Inc. Research & Ratings BTAI Barron

Btai analyst ratings

Analyst Forecast For BioXcel Therapeutics Inc. (NASDAQ: BTAI)

WebApr 11, 2024 · BioXcel Therapeutics (NASDAQ:BTAI – Get Rating) last posted its … WebApr 12, 2024 · BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Rating) Director Krishnan Nandabalan sold 60,000 shares of BioXcel Therapeutics stock in a transaction dated Thursday, April 6th.The shares were sold at an average price of $17.32, for a total transaction of $1,039,200.00. The sale was disclosed in a filing with the Securities & …

Did you know?

Web5 rows · See BioXcel Therapeutics, Inc. (BTAI) stock analyst estimates, including earnings and revenue, ... WebFeb 8, 2024 · The analyst revisited the BTAI model based on BXCL501 in schizophrenia, bipolar disorder, AD, and major depressive disorder (MDD), raising the peak sales estimate to $1.2 billion (vs. prior...

Web0. According to 22 analyst offering 12-month price targets in the last 3 months, Booking Holdings has an average price target of $2752.23 with a high of $3430.00 and a low of $2300.00. Below is a ... WebMar 29, 2024 · BTAI Stock Price Targets and Analyst Ratings BioXcel Therapeutics Inc. Stock NASDAQ: BTAI Open Broker Account NASDAQ Stock Exchange > Healthcare > Biotechnology $18.08 (2.15%) Volume: 574.484k Closed: Mar 29, 2024 Score: -4.178 Chart & Forecast Price Targets & Analyst Ratings Earnings Reports Discussion Insider …

WebApr 6, 2024 · Analyst Forecast According to 16 analysts, the average rating for BTAI … WebFeb 28, 2024 · BioXcel Therapeutics Inc. research and ratings by Barron's. View BTAI …

WebApr 10, 2024 · Bioxcel Therapeutics (BTAI) In a report released today, Greg Harrison from Bank of America Securities reiterated a Buy rating on Bioxcel Therapeutics, with a price target of $43.00. The company ...

WebBased on analysts offering 12 month price targets for BTAI in the last 3 months. The … branning princetonWebApr 14, 2024 · 70. See BTAI Report. InvestorsObserver is giving BioXcel Therapeutics Inc (BTAI) an Analyst Rating Rank of 73, meaning BTAI is ranked higher by analysts than 73% of stocks. The average price target for BTAI is $101.5 and analyst’s rate the stock as a Strong Buy. Wall Street analysts are rating BTAI a Strong Buy today. hair down with flowersWebBioxcel Therapeutics Inc (BTAI) has a Smart Score of 7 based on an analysis of 8 unique … hair down to the floor